Deciphering the Potentials of Cardamom in Cancer Prevention and Therapy: From Kitchen to Clinic

Area of Science:

• Phytochemistry
• Oncology
• Pharmacology

Background:

• Cardamom, a spice from Zingiberaceae family plants, possesses antioxidant, antimicrobial, and anti-inflammatory properties.
• Preclinical studies suggest cardamom's potential in cancer risk reduction and management.
• Cardamom contains various phytochemicals with potential anti-cancer activities.

Purpose of the Study:

• To review the medicinal properties and pharmacological uses of cardamom.
• To explore cardamom's cellular effects and therapeutic potential in cancer prevention and treatment.
• To assess cardamom's role in overcoming drug resistance and mitigating chemotherapy toxicity.

Main Methods:

• Literature review of preclinical studies on cardamom's anti-cancer properties.
• Analysis of phytochemical compounds in cardamom and their mechanisms of action.
• Evaluation of cardamom's effects on cancer cells and chemotherapy-induced toxicity.

Main Results:

• Cardamom phytochemicals target the programmed cell death lignin-1 gene, prevalent in cancer cells.
• Cardamom demonstrated potential in overcoming drug resistance and reducing chemotherapy toxicity.
• Compounds like limonene, cardamonin, and indole-3-carbinol show anti-cancer effects.

Conclusions:

• Cardamom exhibits significant potential as an anti-cancer agent based on preclinical evidence.
• Its diverse mechanisms of action warrant further investigation for clinical applications.
• Cardamom may improve overall health and treatment outcomes for cancer patients.